Zhuoran Tang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 24, 2024
Selective Depletion of CCR8+Treg Cells Enhances the Antitumor Immunity of Cytotoxic T Cells in Lung Cancer by Dendritic Cells.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: September 24, 2024
Machine learning identifies immune-based biomarkers that predict efficacy of anti-angiogenesis-based therapies in advanced lung cancer.
Journal: International immunopharmacology
Published: May 24, 2024
CXCR1+ neutrophil infiltration orchestrates response to third-generation EGFR-TKI in EGFR mutant non-small-cell lung cancer.
Journal: Signal transduction and targeted therapy
Published: May 18, 2024
Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma.
Journal: Frontiers in immunology
Published: September 20, 2023
Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
Journal: Lung Cancer (Auckland, N.Z.)
Published: August 31, 2023
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations.
Journal: Translational lung cancer research
Published: August 25, 2022
Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer.
Journal: Frontiers in genetics
Published: July 25, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026